PBM Uses Prescriptive Clinical AI to Reduce Medication Non-adherence and Improve Quality Ratings

Medication non-adherence contributes to approximately $300 billion in avoidable medical expenditures per year. Excluding fraud, that’s 30% of all waste in the healthcare system.

Estimates suggest that as many as three quarters of patients do not take their medications as directed. As a result, medication non-adherence contributes to $290 billion in avoidable medical expenditures per year. To raise adherence rates and bring these costs down, pharmacy benefit managers (PBMs) need to act at the root causes of non-adherence. Sometimes non-adherence is due to prescription-related factors, such as negative side effects. In other cases, social determinants of health, such as low health literacy or access to a pharmacy, are the culprit. To address these risk factors in their member population, one PBM with 20 million members turned to the prescriptive clinical artificial intelligence of the Jvion CORE™.


  • Download the impact story to learn how the CORE helped the PBM identify who was at risk of non-adherence, why they were at risk, and what interventions and outreach channels would most effectively reduce their members’ risk. Of the members identified to be at risk, nearly 80% would impact the PBM’s STAR rating.

  • We respect your privacy.
  • This field is for validation purposes and should be left unchanged.

Get in Touch

  • 470-427-2900, 3965 Johns Creek Court, Suite 100, Suwanee, GA 30024
  • This field is for validation purposes and should be left unchanged.

Request a demo

  • Download the latest SmartFocus paper “The COVID Aftermath: Why behavioral health is the next crisis health plans should be prepared to manage” brought to you by Jvion and SmartBrief to understand why the current state of analytics leave members and health plans exposed to a behavioral health crisis.

  • We respect your privacy.
  • This field is for validation purposes and should be left unchanged.